Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 150 Pages
Report ld: 3500868
Request Sample
Customized Report
Hepatitis B Test Strip Market Size(US$)

CAGR 2025-2031
4.3%
Market Size,2031
USD 178
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Hepatitis B Test Strip was estimated to be worth US$ 133 million in 2024 and is forecast to a readjusted size of US$ 178 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
North American market for Hepatitis B Test Strip was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Hepatitis B Test Strip was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Hepatitis B Test Strip was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Hepatitis B Test Strip include Biopanda Reagents, CTK Biotech, AccuBioTech, BTNX, Nectar Lifesciences, Hangzhou Aichek Medical Technology Co.,Ltd, Xiamen Boson Biotech Co., Ltd., Henso Medical, Goldenmed Biomedical Nantong Inc., Hunan Runmei Gene Technology Co., Ltd., etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Hepatitis B Test Strip, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hepatitis B Test Strip by region & country, by Type, and by Application.
The Hepatitis B Test Strip market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B Test Strip.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hepatitis B Test Strip manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Hepatitis B Test Strip in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Hepatitis B Test Strip in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Hepatitis B Test Strip Product Introduction
1.2 Global Hepatitis B Test Strip Market Size Forecast
1.2.1 Global Hepatitis B Test Strip Sales Value (2020-2031)
1.2.2 Global Hepatitis B Test Strip Sales Volume (2020-2031)
1.2.3 Global Hepatitis B Test Strip Sales Price (2020-2031)
1.3 Hepatitis B Test Strip Market Trends & Drivers
1.3.1 Hepatitis B Test Strip Industry Trends
1.3.2 Hepatitis B Test Strip Market Drivers & Opportunity
1.3.3 Hepatitis B Test Strip Market Challenges
1.3.4 Hepatitis B Test Strip Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hepatitis B Test Strip Players Revenue Ranking (2024)
2.2 Global Hepatitis B Test Strip Revenue by Company (2020-2025)
2.3 Global Hepatitis B Test Strip Players Sales Volume Ranking (2024)
2.4 Global Hepatitis B Test Strip Sales Volume by Company Players (2020-2025)
2.5 Global Hepatitis B Test Strip Average Price by Company (2020-2025)
2.6 Key Manufacturers Hepatitis B Test Strip Manufacturing Base and Headquarters
2.7 Key Manufacturers Hepatitis B Test Strip Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Hepatitis B Test Strip
2.9 Hepatitis B Test Strip Market Competitive Analysis
2.9.1 Hepatitis B Test Strip Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Hepatitis B Test Strip Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Test Strip as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 HBcAb Test Strip
3.1.2 HBeAb Test Strip
3.1.3 HBeAg Test Strip
3.1.4 HBsAb Test Strip
3.1.5 HBsAg Test Strip
3.2 Global Hepatitis B Test Strip Sales Value by Type
3.2.1 Global Hepatitis B Test Strip Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Hepatitis B Test Strip Sales Value, by Type (2020-2031)
3.2.3 Global Hepatitis B Test Strip Sales Value, by Type (%) (2020-2031)
3.3 Global Hepatitis B Test Strip Sales Volume by Type
3.3.1 Global Hepatitis B Test Strip Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Hepatitis B Test Strip Sales Volume, by Type (2020-2031)
3.3.3 Global Hepatitis B Test Strip Sales Volume, by Type (%) (2020-2031)
3.4 Global Hepatitis B Test Strip Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Household
4.1.2 Hospital
4.1.3 Clinic
4.1.4 Others
4.2 Global Hepatitis B Test Strip Sales Value by Application
4.2.1 Global Hepatitis B Test Strip Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Hepatitis B Test Strip Sales Value, by Application (2020-2031)
4.2.3 Global Hepatitis B Test Strip Sales Value, by Application (%) (2020-2031)
4.3 Global Hepatitis B Test Strip Sales Volume by Application
4.3.1 Global Hepatitis B Test Strip Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Hepatitis B Test Strip Sales Volume, by Application (2020-2031)
4.3.3 Global Hepatitis B Test Strip Sales Volume, by Application (%) (2020-2031)
4.4 Global Hepatitis B Test Strip Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Hepatitis B Test Strip Sales Value by Region
5.1.1 Global Hepatitis B Test Strip Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Hepatitis B Test Strip Sales Value by Region (2020-2025)
5.1.3 Global Hepatitis B Test Strip Sales Value by Region (2026-2031)
5.1.4 Global Hepatitis B Test Strip Sales Value by Region (%), (2020-2031)
5.2 Global Hepatitis B Test Strip Sales Volume by Region
5.2.1 Global Hepatitis B Test Strip Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Hepatitis B Test Strip Sales Volume by Region (2020-2025)
5.2.3 Global Hepatitis B Test Strip Sales Volume by Region (2026-2031)
5.2.4 Global Hepatitis B Test Strip Sales Volume by Region (%), (2020-2031)
5.3 Global Hepatitis B Test Strip Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Hepatitis B Test Strip Sales Value, 2020-2031
5.4.2 North America Hepatitis B Test Strip Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Hepatitis B Test Strip Sales Value, 2020-2031
5.5.2 Europe Hepatitis B Test Strip Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Hepatitis B Test Strip Sales Value, 2020-2031
5.6.2 Asia Pacific Hepatitis B Test Strip Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Hepatitis B Test Strip Sales Value, 2020-2031
5.7.2 South America Hepatitis B Test Strip Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Hepatitis B Test Strip Sales Value, 2020-2031
5.8.2 Middle East & Africa Hepatitis B Test Strip Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hepatitis B Test Strip Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Hepatitis B Test Strip Sales Value
6.2.1 Key Countries/Regions Hepatitis B Test Strip Sales Value, 2020-2031
6.2.2 Key Countries/Regions Hepatitis B Test Strip Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Hepatitis B Test Strip Sales Value, 2020-2031
6.3.2 United States Hepatitis B Test Strip Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Hepatitis B Test Strip Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Hepatitis B Test Strip Sales Value, 2020-2031
6.4.2 Europe Hepatitis B Test Strip Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Hepatitis B Test Strip Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Hepatitis B Test Strip Sales Value, 2020-2031
6.5.2 China Hepatitis B Test Strip Sales Value by Type (%), 2024 VS 2031
6.5.3 China Hepatitis B Test Strip Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Hepatitis B Test Strip Sales Value, 2020-2031
6.6.2 Japan Hepatitis B Test Strip Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Hepatitis B Test Strip Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Hepatitis B Test Strip Sales Value, 2020-2031
6.7.2 South Korea Hepatitis B Test Strip Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Hepatitis B Test Strip Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Hepatitis B Test Strip Sales Value, 2020-2031
6.8.2 Southeast Asia Hepatitis B Test Strip Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Hepatitis B Test Strip Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Hepatitis B Test Strip Sales Value, 2020-2031
6.9.2 India Hepatitis B Test Strip Sales Value by Type (%), 2024 VS 2031
6.9.3 India Hepatitis B Test Strip Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Biopanda Reagents
7.1.1 Biopanda Reagents Company Information
7.1.2 Biopanda Reagents Introduction and Business Overview
7.1.3 Biopanda Reagents Hepatitis B Test Strip Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Biopanda Reagents Hepatitis B Test Strip Product Offerings
7.1.5 Biopanda Reagents Recent Development
7.2 CTK Biotech
7.2.1 CTK Biotech Company Information
7.2.2 CTK Biotech Introduction and Business Overview
7.2.3 CTK Biotech Hepatitis B Test Strip Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 CTK Biotech Hepatitis B Test Strip Product Offerings
7.2.5 CTK Biotech Recent Development
7.3 AccuBioTech
7.3.1 AccuBioTech Company Information
7.3.2 AccuBioTech Introduction and Business Overview
7.3.3 AccuBioTech Hepatitis B Test Strip Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 AccuBioTech Hepatitis B Test Strip Product Offerings
7.3.5 AccuBioTech Recent Development
7.4 BTNX
7.4.1 BTNX Company Information
7.4.2 BTNX Introduction and Business Overview
7.4.3 BTNX Hepatitis B Test Strip Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 BTNX Hepatitis B Test Strip Product Offerings
7.4.5 BTNX Recent Development
7.5 Nectar Lifesciences
7.5.1 Nectar Lifesciences Company Information
7.5.2 Nectar Lifesciences Introduction and Business Overview
7.5.3 Nectar Lifesciences Hepatitis B Test Strip Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Nectar Lifesciences Hepatitis B Test Strip Product Offerings
7.5.5 Nectar Lifesciences Recent Development
7.6 Hangzhou Aichek Medical Technology Co.,Ltd
7.6.1 Hangzhou Aichek Medical Technology Co.,Ltd Company Information
7.6.2 Hangzhou Aichek Medical Technology Co.,Ltd Introduction and Business Overview
7.6.3 Hangzhou Aichek Medical Technology Co.,Ltd Hepatitis B Test Strip Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Hangzhou Aichek Medical Technology Co.,Ltd Hepatitis B Test Strip Product Offerings
7.6.5 Hangzhou Aichek Medical Technology Co.,Ltd Recent Development
7.7 Xiamen Boson Biotech Co., Ltd.
7.7.1 Xiamen Boson Biotech Co., Ltd. Company Information
7.7.2 Xiamen Boson Biotech Co., Ltd. Introduction and Business Overview
7.7.3 Xiamen Boson Biotech Co., Ltd. Hepatitis B Test Strip Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Xiamen Boson Biotech Co., Ltd. Hepatitis B Test Strip Product Offerings
7.7.5 Xiamen Boson Biotech Co., Ltd. Recent Development
7.8 Henso Medical
7.8.1 Henso Medical Company Information
7.8.2 Henso Medical Introduction and Business Overview
7.8.3 Henso Medical Hepatitis B Test Strip Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Henso Medical Hepatitis B Test Strip Product Offerings
7.8.5 Henso Medical Recent Development
7.9 Goldenmed Biomedical Nantong Inc.
7.9.1 Goldenmed Biomedical Nantong Inc. Company Information
7.9.2 Goldenmed Biomedical Nantong Inc. Introduction and Business Overview
7.9.3 Goldenmed Biomedical Nantong Inc. Hepatitis B Test Strip Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Goldenmed Biomedical Nantong Inc. Hepatitis B Test Strip Product Offerings
7.9.5 Goldenmed Biomedical Nantong Inc. Recent Development
7.10 Hunan Runmei Gene Technology Co., Ltd.
7.10.1 Hunan Runmei Gene Technology Co., Ltd. Company Information
7.10.2 Hunan Runmei Gene Technology Co., Ltd. Introduction and Business Overview
7.10.3 Hunan Runmei Gene Technology Co., Ltd. Hepatitis B Test Strip Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Hunan Runmei Gene Technology Co., Ltd. Hepatitis B Test Strip Product Offerings
7.10.5 Hunan Runmei Gene Technology Co., Ltd. Recent Development
7.11 Zhejiang Orient Gene Biotech Co.,Ltd.
7.11.1 Zhejiang Orient Gene Biotech Co.,Ltd. Company Information
7.11.2 Zhejiang Orient Gene Biotech Co.,Ltd. Introduction and Business Overview
7.11.3 Zhejiang Orient Gene Biotech Co.,Ltd. Hepatitis B Test Strip Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Zhejiang Orient Gene Biotech Co.,Ltd. Hepatitis B Test Strip Product Offerings
7.11.5 Zhejiang Orient Gene Biotech Co.,Ltd. Recent Development
7.12 Nantong Egens Biotechnology Co. Ltd
7.12.1 Nantong Egens Biotechnology Co. Ltd Company Information
7.12.2 Nantong Egens Biotechnology Co. Ltd Introduction and Business Overview
7.12.3 Nantong Egens Biotechnology Co. Ltd Hepatitis B Test Strip Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Nantong Egens Biotechnology Co. Ltd Hepatitis B Test Strip Product Offerings
7.12.5 Nantong Egens Biotechnology Co. Ltd Recent Development
7.13 Alere
7.13.1 Alere Company Information
7.13.2 Alere Introduction and Business Overview
7.13.3 Alere Hepatitis B Test Strip Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Alere Hepatitis B Test Strip Product Offerings
7.13.5 Alere Recent Development
7.14 Biosynex
7.14.1 Biosynex Company Information
7.14.2 Biosynex Introduction and Business Overview
7.14.3 Biosynex Hepatitis B Test Strip Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Biosynex Hepatitis B Test Strip Product Offerings
7.14.5 Biosynex Recent Development
7.15 Cepheid
7.15.1 Cepheid Company Information
7.15.2 Cepheid Introduction and Business Overview
7.15.3 Cepheid Hepatitis B Test Strip Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Cepheid Hepatitis B Test Strip Product Offerings
7.15.5 Cepheid Recent Development
7.16 MedMira
7.16.1 MedMira Company Information
7.16.2 MedMira Introduction and Business Overview
7.16.3 MedMira Hepatitis B Test Strip Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 MedMira Hepatitis B Test Strip Product Offerings
7.16.5 MedMira Recent Development
7.17 TURKLAB
7.17.1 TURKLAB Company Information
7.17.2 TURKLAB Introduction and Business Overview
7.17.3 TURKLAB Hepatitis B Test Strip Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 TURKLAB Hepatitis B Test Strip Product Offerings
7.17.5 TURKLAB Recent Development
7.18 Shanghai Rongsheng Biotech Co., Ltd.
7.18.1 Shanghai Rongsheng Biotech Co., Ltd. Company Information
7.18.2 Shanghai Rongsheng Biotech Co., Ltd. Introduction and Business Overview
7.18.3 Shanghai Rongsheng Biotech Co., Ltd. Hepatitis B Test Strip Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Shanghai Rongsheng Biotech Co., Ltd. Hepatitis B Test Strip Product Offerings
7.18.5 Shanghai Rongsheng Biotech Co., Ltd. Recent Development
7.19 Standard Diagnostics
7.19.1 Standard Diagnostics Company Information
7.19.2 Standard Diagnostics Introduction and Business Overview
7.19.3 Standard Diagnostics Hepatitis B Test Strip Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 Standard Diagnostics Hepatitis B Test Strip Product Offerings
7.19.5 Standard Diagnostics Recent Development
8 Industry Chain Analysis
8.1 Hepatitis B Test Strip Industrial Chain
8.2 Hepatitis B Test Strip Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Hepatitis B Test Strip Sales Model
8.5.2 Sales Channel
8.5.3 Hepatitis B Test Strip Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Hepatitis B Test Strip was estimated to be worth US$ 138 million in 2025 and is projected to reach US$ 185 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 148
USD 3950.00
(Single User License)
The global Hepatitis B Test Strip market was valued at US$ 138 million in 2025 and is anticipated to reach US$ 185 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 136
USD 2900.00
(Single User License)
The global Hepatitis B Test Strip market size was US$ 133 million in 2024 and is forecast to a readjusted size of US$ 178 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 105
USD 4250.00
(Single User License)
The global Hepatitis B Test Strip market is projected to grow from US$ 133 million in 2024 to US$ 178 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 171
USD 4900.00
(Single User License)
The global market for Hepatitis B Test Strip was valued at US$ 133 million in the year 2024 and is projected to reach a revised size of US$ 178 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published Date: 2025-01-13
Pages: 104
USD 2900.00
(Single User License)
The global Hepatitis B Test Strip market was valued at US$ 124 million in 2023 and is anticipated to reach US$ 164.8 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
Published Date: 2024-01-17
Pages: 100
USD 2900.00
(Single User License)
The global market for Hepatitis B Test Strip was estimated to be worth US$ 138 million in 2025 and is projected to reach US$ 185 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-06-16
Pages: 148
The global Hepatitis B Test Strip market was valued at US$ 138 million in 2025 and is anticipated to reach US$ 185 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-04-17
Pages: 136
The global Hepatitis B Test Strip market size was US$ 133 million in 2024 and is forecast to a readjusted size of US$ 178 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 105
The global Hepatitis B Test Strip market is projected to grow from US$ 133 million in 2024 to US$ 178 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 171
The global market for Hepatitis B Test Strip was valued at US$ 133 million in the year 2024 and is projected to reach a revised size of US$ 178 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published: 2025-01-13
Pages: 104
The global Hepatitis B Test Strip market was valued at US$ 124 million in 2023 and is anticipated to reach US$ 164.8 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
Published: 2024-01-17
Pages: 100
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now